thiophenes has been researched along with zoledronic acid in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (30.77) | 29.6817 |
2010's | 8 (61.54) | 24.3611 |
2020's | 1 (7.69) | 2.80 |
Authors | Studies |
---|---|
Biskobing, DM; Downs, R; Novy, AM | 1 |
Geusens, P; Reid, D | 1 |
Delmas, PD; Vignot, E | 1 |
Fukawa, T; Kamiya, S; Wada, S | 1 |
Bolland, MJ; Gamble, GD; Grey, AB; Reid, IR | 1 |
Chen, B; Li, Y; Xie, D; Xu, H; Yang, X | 1 |
Bouvet, A; Caruba, T; Pouchot, J; Sabatier, B; Savoldelli, V | 1 |
Reid, IR | 1 |
Chen, LX; Feng, SQ; Li, YL; Ning, GZ; Zhang, D; Zhang, TS; Zhou, ZR | 1 |
Eiken, P; Vestergaard, P | 1 |
Dempster, DW; Moreira, CA | 1 |
Ding, GZ; Tao, ZS; Wang, L; Wu, XJ; Xie, JB; Xu, ZJ; Yang, M; Zhang, X; Zhou, WS | 1 |
Andreis, JD; Castro, ML; Claudino, M; Delfrate, G; Fischborn, AR; Franco, GCN; Mecca, LEA; Mroczek, T; Oliveira, FB; Rigo, NM; Taba Junior, M | 1 |
6 review(s) available for thiophenes and zoledronic acid
Article | Year |
---|---|
Novel therapeutic options for osteoporosis.
Topics: Animals; Controlled Clinical Trials as Topic; Diphosphonates; Disease Models, Animal; Evidence-Based Medicine; Fractures, Spontaneous; Glycoproteins; Humans; Ibandronic Acid; Imidazoles; Norpregnenes; Osteoporosis; Osteoprotegerin; Piperidines; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Selective Estrogen Receptor Modulators; Thiophenes; Zoledronic Acid | 2002 |
Newer drug treatments: their effects on fracture prevention.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bone Density; Bone Density Conservation Agents; Calcitonin; Denosumab; Diphosphonates; Fractures, Bone; Glycoproteins; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ibandronic Acid; Imidazoles; Organometallic Compounds; Osteoporosis; Osteoprotegerin; Parathyroid Hormone; RANK Ligand; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Thiophenes; Zoledronic Acid | 2005 |
[Newly developed drugs for osteoporosis in overseas and their future roles for the therapy].
Topics: Anabolic Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Bone Resorption; Denosumab; Diphosphonates; Drug Design; Evidence-Based Medicine; Fractures, Bone; Humans; Imidazoles; Indoles; Organometallic Compounds; Osteoporosis; RANK Ligand; Selective Estrogen Receptor Modulators; Teriparatide; Thiophenes; Zoledronic Acid | 2008 |
Effect of osteoporosis treatment on mortality: a meta-analysis.
Topics: Age Factors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Denosumab; Diphosphonates; Etidronic Acid; Fractures, Bone; Humans; Imidazoles; Organometallic Compounds; Osteoporosis; Randomized Controlled Trials as Topic; RANK Ligand; Risedronic Acid; Thiophenes; Treatment Outcome; Zoledronic Acid | 2010 |
Comparison of Bone Mineral Density in Lumbar Spine and Fracture Rate among Eight Drugs in Treatments of Osteoporosis in Men: A Network Meta-Analysis.
Topics: Alendronate; Bone Density; Bone Density Conservation Agents; Diphosphonates; Fractures, Bone; Humans; Hydroxycholecalciferols; Ibandronic Acid; Imidazoles; Lumbar Vertebrae; Osteoporosis; Parathyroid Hormone; Risedronic Acid; Teriparatide; Thiophenes; Zoledronic Acid | 2015 |
Treatment of osteoporosis after alendronate or risedronate.
Topics: Alendronate; Bone Density Conservation Agents; Diphosphonates; Drug Substitution; Female; Humans; Imidazoles; Osteoporosis, Postmenopausal; Risedronic Acid; Teriparatide; Thiophenes; Zoledronic Acid | 2016 |
7 other study(ies) available for thiophenes and zoledronic acid
Article | Year |
---|---|
[Advances in the field of osteoporosis].
Topics: Absorptiometry, Photon; Adult; Bone Density; Bone Density Conservation Agents; Child; Diphosphonates; Female; Glucocorticoids; Humans; Hypogonadism; Imidazoles; Male; Middle Aged; Organometallic Compounds; Osteoporosis; Teriparatide; Thiophenes; Zoledronic Acid | 2007 |
Zoledronic acid enhances bone-implant osseointegration more than alendronate and strontium ranelate in ovariectomized rats.
Topics: Alendronate; Animals; Bone Density; Bone Density Conservation Agents; Diphosphonates; Drug Evaluation, Preclinical; Female; Femur; Humans; Imidazoles; Materials Testing; Orthopedic Fixation Devices; Osseointegration; Osteoporosis, Postmenopausal; Ovariectomy; Prostheses and Implants; Rats; Stress, Mechanical; Thiophenes; Tibia; Titanium; Zoledronic Acid | 2013 |
Evaluation of the prescription of osteoporosis treatment after a major osteoporotic fracture.
Topics: Aged; Aged, 80 and over; Bone Density Conservation Agents; Calcium; Dietary Supplements; Diphosphonates; Female; Follow-Up Studies; Fractures, Bone; France; Hip Fractures; Humans; Imidazoles; Male; Middle Aged; Osteoporosis; Osteoporotic Fractures; Prescriptions; Raloxifene Hydrochloride; Retrospective Studies; Thiophenes; Treatment Outcome; Vitamin D; Wrist Injuries; Zoledronic Acid | 2014 |
Efficacy, effectiveness and side effects of medications used to prevent fractures.
Topics: Alendronate; Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Calcium Compounds; Denosumab; Diphosphonates; Etidronic Acid; Evidence-Based Medicine; Hip Fractures; Humans; Ibandronic Acid; Imidazoles; Osteoporosis; Osteoporotic Fractures; Raloxifene Hydrochloride; Risedronic Acid; Risk Assessment; Spinal Fractures; Teriparatide; Thiophenes; Treatment Outcome; Vitamin D; Zoledronic Acid | 2015 |
Histomorphometric changes following treatment for osteoporosis.
Topics: Anabolic Agents; Bone and Bones; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Clinical Trials as Topic; Humans; Osteoporosis; Teriparatide; Thiophenes; Treatment Outcome; Zoledronic Acid | 2017 |
Prevention of ovariectomy-induced osteoporosis in rats : Comparative study of zoledronic acid, parathyroid hormone (1-34) and strontium ranelate.
Topics: Animals; Bone Density Conservation Agents; Female; Osteoporosis; Ovariectomy; Parathyroid Hormone; Rats; Rats, Sprague-Dawley; Thiophenes; X-Ray Microtomography; Zoledronic Acid | 2019 |
Absence of medication-related jaw osteonecrosis after treatment with strontium ranelate in ovariectomized rats.
Topics: Animals; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Diphosphonates; Female; Osteonecrosis; Rats; Thiophenes; Tooth Extraction; Zoledronic Acid | 2022 |